1 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424. 2 Liu J.Control of protein synthesis and mRNA degradation by microRNAs[J].Curr Opin Cell Biol,2008,20(2):214-21. 3 Cavatorta O,Scida S,Miraglia C,et al.Epidemiology of gastric cancer and risk factors[J].Acta Biomed,2018,89(8):82-87. 4 Ying SY,Chang DC,Lin SL.The MicroRNA[J].Methods Mol Biol,2018,1733:1-25. 5 Fish JE,Santoro MM,Morton SU,et al.miR-126 regulates angiogenic signaling and vascular integrity[J].Dev Cell,2008,15(2):272-284. 6 Ebrahimi F,Gopalan V,Smith RA,et al.miR-126 in human cancers:clinical roles and current perspectives[J].Exp Mol Pathol,2014,96(1):98-107. 7 Feng R,Chen X,Yu Y,et al.miR-126 functions as a tumour suppressor in human gastric cancer[J].Cancer Lett,2010,298(1):50-63. 8 Hu M,Xiong S,Chen Q,et al.Novel role of microRNA-126 in digestive system cancers:from bench to bedside[J].Oncol Lett,2019,17(1):31-41. 9 Yuan W,Guo YQ,Li XY,et al.MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine(C-X-C motif)receptor 4 and Ras homolog gene family,member A,signaling pathway[J].Oncotarget,2016,7(37):60230-60244. 10 Karmakar S,Kaushik G,Nimmakayala R,et al.MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention[J].Semin Cancer Biol,2019,54:63-71. 11 Frampton AE,Krell J,Jacob J,et al.Loss of miR-126 is crucial to pancreatic cancer progression[J].Expert Rev Anticancer Ther,2012,12(7):881-884. 12 Jobin PG,Butler GS,Overall CM.New intracellular activities of matrix metalloproteinases shine in the moonlight[J].Biochim Biophys Acta Mol Cell Res,2017,1864(11):2043-2055. 13 Gobin E,Bagwell K,Wagner J,et al.A pan-cancer perspective of matrix metalloproteases(MMP)gene expression profile and their diagnostic/prognostic potential[J].BMC Cancer,2019,19(1):581. |